טוען...
Advances in new drug therapies for the management of sickle cell disease
INTRODUCTION: Sickle cell disease (SCD) is an orphan disease in the United States, but is highly prevalent worldwide. Only two drugs, hydroxyurea and L-glutamine, are approved for this disease. With an improved understanding of the pathophysiology of SCD as well as the success of several recently ap...
שמור ב:
| הוצא לאור ב: | Expert Opin Orphan Drugs |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6411095/ https://ncbi.nlm.nih.gov/pubmed/30873300 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21678707.2018.1471983 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|